<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Medicare Program; Application by the Utilization Review Accreditation Commission (URAC) for Continued CMS Approval of Its Home Infusion Therapy (HIT) Accreditation Program</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <style>
        body { font-family: Arial, sans-serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { color: #333; }
        .metadata { color: #666; font-size: 0.9em; }
        .summary { margin-top: 20px; line-height: 1.5; }
        .source { margin-top: 20px; }
    </style>
</head>
<body>
    <h1>Medicare Program; Application by the Utilization Review Accreditation Commission (URAC) for Continued CMS Approval of Its Home Infusion Therapy (HIT) Accreditation Program</h1>
    <div class="metadata">Published: 2026-02-05 12:25:45</div>
    <div class="summary">This notice acknowledges the receipt of an application from the Utilization Review Accreditation Commission (URAC) for continued approval by the Centers for Medicare & Medicaid Services (CMS) of URAC's national accrediting organization program for suppliers providing home infusion therapy (HIT) services and that wish to participate in the Medicare or Medicaid programs. The statute requires that within 60 days of receipt of an organization's complete application, CMS will publish a notice that identifies the national accrediting body making the request, describes the nature of the request, and provides at least a 30-day public comment period.</div>
    <div class="source">Source: <a href="https://www.federalregister.gov/documents/2023/11/09/2023-24850/medicare-program-application-by-the-utilization-review-accreditation-commission-urac-for-continued" target="_blank" rel="noopener noreferrer">https://www.federalregister.gov/documents/2023/11/09/2023-24850/medicare-program-application-by-the-utilization-review-accreditation-commission-urac-for-continued</a></div>
</body>
</html>
